Amalia M. Issa, MPH, Ph.D.
Associate Professor, College of Technology, University of Houston
and Director, Program in Personalized Medicine and Targeted Therapeutics, Abramson Family Center for the Future of Health
"Personalized Medicine and the Future of the Pharmaceutical Industry"
The revolution heralded by personalized medicine - the use of genetic information including molecular markers to develop drugs targeted to serve the individual patient's particular condition and side effects profile - is shifting the terrain of drug discovery and development.
What are the key challenges and issues facing scientists and the pharmaceutical industry? How might the future look? In this presentation, participants will learn how the process of discovering and developing innovative pharmaceuticals is evolving, and how personalized medicine is driving a drug discovery paradigm shift.